856410-07-6

Upstream product

• 108735-94-0 1-Ethyl 4-methyl 2-hydroxy 3-methylenebutanedioate 
• 856410-03-2 1-ethyl 4-methyl 2-trichloroacetylaminocarbonyloxy-3-methylenebutandioate 
• 856410-05-4 1-ethyl 4-methyl 2-trichloroacetiminoxy-3-methylidenebutanedioate 
• 856410-04-3 1-ethyl 4-methyl 2-trichloroacetylamino-3-methylidenebutanedioate 
• 2627-86-3 (S)-1-phenyl-ethylamine 

Downstream Products

• 1050504-29-4 [(3S,4R)-4-amino-1-[(S)-1-phenylethyl]pyrrolidin-3-yl]methanol 
• 1206626-25-6 (3R,4R,1'S)-4-allyl-4-methoxycarbonyl-1-(1'-phenyleth-1'-yl)-3-trichloroacetylaminopyrrolidin-2-one 
• 1206626-24-5 (3R,4S,1'S)-4-allyl-4-methoxycarbonyl-1-(1'-phenyleth-1'-yl)-3-trichloroacetylaminopyrrolidin-2-one 

Relevant academic research and scientific papers

NEW SYNTHONS FOR THE SYNTHESIS OF CHIRAL PEPTIDE NUCLEIC ACIDS AND METHODS FOR PREPARING THE SAME

Novel l-acyl-3-amino-4-hydroxymethylpyiτolidine derivatives useful as PNA synthons optionally having protecting groups suitable of removal under mild conditions are disclosed having the formula (E) wherein: R1 is H or R-C(=O), wherein R is stra

Conformationally restricted analogues of both (S)-β-homoserine and (S)-aspartic acid from chiral 3-acylamino pyrrolidin-2-ones

Starting from chiral 3,4-trans-disubstituted pyrrolidin-2-ones 11a and 11b, obtained from a Baylis-Hillman adduct, conformationally restricted analogues of both (S)-β-homoserine, 17, and (S)-aspartic acid, 21, were synthesized, respectively, and these com